VITAMINS@WORK
ActiveSummary
The annual accounts of VITAMINS@WORK for financial year 2025 show a net loss of 67% of total assets. The 2025 annual accounts show equity of €580,783 and a net result of -€539,337. Equity is shrinking by about 20% per year across the filed financial years. Its solvency ranks better than 72% of 3,321 sector peers (NACE 62, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.6% (low).
History
Acts, filings and financial milestones
02-10
Gazette deed
Resignation: Bert Schreurs (director)Correction · Power of attorney8 facts ▸
- Board meeting, 24-08-2026
- Director resignation, Bert Schreurs (director)
- Correction, vermeldde ontslag ingang 01-07-2026 door algemene vergadering, correctie van publicatie 26103672
- Power of attorney, Luc Wynant
- Power of attorney, Ruben Toelen
- Power of attorney, Inès du Parc Locmaria
- Power of attorney, Emma Van den Bergh
- Power of attorney, Louise-Cécile Lauwers
12-08
Gazette deed
Resignation: Bert Schreurs (director)2 facts ▸
- General meeting, 01-07-2026
- Director resignation, Bert Schreurs (director)
05-05
Gazette deed
Resignations: Christophe Reynaert (director) and JGW Management Services BV (day-to-day manager)Permanent representative: Jonas Geleyn · Appointments: Jonas Scheers, Bert Schreurs and Patrick De Pauw · Power of attorney8 facts ▸
- General meeting, 01-10-2025
- Director resignation, Christophe Reynaert (director)
- Director resignation, JGW Management Services BV (day-to-day manager)
- Permanent representative, Jonas Geleyn
- Director appointment, Jonas Scheers (director)
- Director appointment, Bert Schreurs (director)
- Director appointment, Patrick De Pauw (director)
- Power of attorney, Coomans Felien
About the unread acts
Of the 8 Belgian Official Gazette deeds we know for this company, 3 have been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.